UCB

Belgium

UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. 

UCB focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson’s, and Crohn’s diseases. The company’s efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system (CNS) disorders (including epilepsy), inflammatory disorders (including allergy), and oncology.

Contact

UCB S.A.
email
address
Allée de la Recherche, 60 1070 Brussels Belgium
phone
+32 2 559 99 99